Ten-Year Follow-Up of the First Megatrial Testing Thrombolytic Therapy in Patients With Acute Myocardial Infarction

1998179 citationsJournal Articlebronze Open Access

Authors

Maria Grazia Franzosi · Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Eugenio Santoro · Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Claudio De Vita · Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Enrico Geraci · Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Antonio Lotto · Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Aldo P. Maggioni · Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Abstract

The benefits of a single intravenous infusion of 1.5 million units of streptokinase in prolonging survival of patients with acute myocardial infarction is sustained up to 10 years, with a still-evident trend in favor of the patients admitted earlier.

Topics & Keywords

Acute Myocardial Infarction Research Coronary Interventions and Diagnostics Cardiac Imaging and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 98, Issue 24, pp. 2659-2665

DOI: 10.1161/01.cir.98.24.2659

Field-Weighted Citation Impact: 9.92